跳至主要内容
临床试验/NL-OMON21444
NL-OMON21444尚未招募不适用

Angiotensin II receptor blockers in patients with systemic right ventricles.

Academic Medical CentreMeibergdreef 91105 AZ AmsterdamThe Netherlands0 个研究点目标入组 128 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
128

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • All adult patients with a systemic right ventricle due to a congenitally or surgically corrected transposition of the great arteries.

排除标准

  • 1. Incapable of giving informed consent;
  • 2. Hypersensitivity to valsartan or any of its help substances;
  • 3. Known bilateral renal artery stenosis;
  • 4. Current symptomatic hypotension;
  • 5. Myocardial infarction, stroke or open-heart surgery in the previous four weeks;
  • 6. Previous heart transplant, or expected heart transplant within the next six months;
  • 7. Plasma creatinine level > 250 µmol/L;
  • 8. Plasma potassium level > 5,5 mmol/L;
  • 9. Pregnant or nursing women (a pregnancy test is offered to every female patient within the fertile age);
  • 10. Desire to have children within the study period;
  • 11. Current treatment of hypertension with Angiotensin II receptor blockers or ACE inhibitors.

研究者

发起方
Academic Medical CentreMeibergdreef 91105 AZ AmsterdamThe Netherlands

相似试验

Angiotensin II receptor blockers in patients with... | 临床试验